Suppr超能文献

马来西亚人群中的结直肠癌生存率:来自马来西亚国家癌症登记处的数据。

Colorectal cancer survival among Malaysia population: data from the Malaysian National Cancer Registry.

作者信息

Muhamad Nor Asiah, Ma'amor Nur Hasnah, Rosli Izzah Athirah, Leman Fatin Norhasny, Abdul Mutalip Mohd Hatta, Chan Huan-Keat, Yusof Siti Norbayah, Tamin Nor Saleha Ibrahim, Aris Tahir, Lai Nai Ming, Abu Hassan Muhammad Radzi

机构信息

Sector for Evidence-based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.

Centre for Communicable Diseases Research, Institutes for Public Health, National Institute of Health, Ministry of Health, Setia Alam, Malaysia.

出版信息

Front Oncol. 2023 Nov 29;13:1132417. doi: 10.3389/fonc.2023.1132417. eCollection 2023.

Abstract

BACKGROUND

Colorectal cancer (CRC) is a major cause of cancer-related mortality worldwide. It is the second leading cause of cancer death in men and women in Malaysia and poses a major burden on society.

AIMS

To determine the overall survival rate of patients diagnosed with CRC and factors contributing to survival.

METHODS

Data were obtained from the Malaysia National Cancer Registry. All patients with CRC were identified, and a total of 15,515 patients were screened. A total of 5,675 CRC patients were included from January 1, 2012, to December 31, 2016. Sex, age groups, ethnic groups, stage at diagnosis, cancer sites, and status of treatment received were analysed. The Kaplan-Meier analysis was performed to estimate the 1-, 3-, and 5-year survival of CRC. The log-rank test was conducted to compare the survival between sex, age groups, ethnic groups, stage at diagnosis, cancer sites, and status of treatment received. Multiple Cox regression was conducted to determine the risk of CRC death.

RESULTS

Of 5,675, a total of 2,055 had died, 3,534 were censored, and another 86 were still alive within 5 years of CRC diagnosis. The 1-, 3-, and 5-year survival rates were 68.5%, 34.7%, and 18.4%, respectively with a median survival time of 24 months. Significant differences in survival rates of CRC were observed between age groups ( < 0.001), ethnic groups ( < 0.001), stages at diagnosis ( < 0.001), treatment status ( = 0.003), and treatment modalities ( < 0.001). No significant difference was observed in survival rates of CRC between sex ( = 0.235) and cancer sites ( = 0.410). Those who were 80 years old and above were found to be at higher risk of CRC death compared to those below 80 years old (adjusted hazard ratio (HR): 1.24, 95% CI 1.14-1.36). The risk of CRC death was also found four times higher among those with stage IV compared to those with stage 0 (adjusted HR: 4.28, 95% CI 3.26-5.62).

CONCLUSION

In general, Malaysian patients with CRC had low survival rates. National health policies should focus on enhancing awareness of CRC, encouraging early screening, and developing strategies for early detection and management to reduce CRC-associated mortality.

摘要

背景

结直肠癌(CRC)是全球癌症相关死亡的主要原因。它是马来西亚男性和女性癌症死亡的第二大原因,给社会带来了重大负担。

目的

确定诊断为结直肠癌患者的总生存率以及影响生存的因素。

方法

数据来自马来西亚国家癌症登记处。识别出所有结直肠癌患者,共筛查了15515例患者。纳入了2012年1月1日至2016年12月31日期间的5675例结直肠癌患者。分析了性别、年龄组、种族、诊断时的分期、癌症部位以及接受治疗的情况。采用Kaplan-Meier分析来估计结直肠癌患者1年、3年和5年的生存率。进行对数秩检验以比较性别、年龄组、种族、诊断时的分期、癌症部位以及接受治疗情况之间的生存率。进行多因素Cox回归以确定结直肠癌死亡风险。

结果

在5675例患者中,共有2055例死亡,3534例被截尾,另有86例在结直肠癌诊断后的5年内仍存活。1年、3年和5年生存率分别为68.5%、34.7%和18.4%,中位生存时间为24个月。在年龄组(<0.001)、种族(<0.001)、诊断时的分期(<0.001)、治疗状态(=0.003)和治疗方式(<0.001)之间观察到结直肠癌生存率存在显著差异。在性别(=0.235)和癌症部位(=0.410)之间未观察到结直肠癌生存率的显著差异。发现80岁及以上的患者与80岁以下的患者相比,结直肠癌死亡风险更高(调整后风险比(HR):1.24,95%可信区间1.14 - 1.36)。还发现IV期患者的结直肠癌死亡风险是0期患者的四倍(调整后HR:4.28,95%可信区间3.26 - 5.62)。

结论

总体而言,马来西亚结直肠癌患者的生存率较低。国家卫生政策应侧重于提高对结直肠癌的认识,鼓励早期筛查,并制定早期检测和管理策略以降低结直肠癌相关死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a910/10718645/b09c124472ac/fonc-13-1132417-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验